Abstract
Background: The dangers of thrombosis are well known and yet current therapy presents a paradox; effective methods of pharmacological anticoagulation are available, but underemployed. The risks associated with the use of anticoagulants, especially warfarin, and the requirement of meticulous dosing with subsequent vigilant monitoring provides some explanation for this discrepancy. Efforts have been made to address this incongruity and increase anticoagulation treatment while mitigating complications; these include the development of dosing nomograms, patient self-monitoring of anticoagulation status, and increased pharmacist participation in anticoagulation management. Although the latter option has proven effective in outpatient clinics, its in-hospital application has received less attention. Therefore, our primary goal was to review the published literature to evaluate the efficacy of in-hospital, pharmacy-managed anticoagulation. In addition, our secondary goals were to assess the potential financial benefit and community acceptance of such pharmacist management.
Methods: Potentially relevant studies were identified by searching PubMed; however, because some pharmacy journals are not included in this database, we also used internet search engines to locate articles. We subsequently employed the Science Citation Index to find additional papers that had referenced articles identified by our initial searches.
Results: Several pilot studies, focusing primarily on adherence to warfarin dosing guidelines, found general equivalence between pharmacist and physician management and specifically illustrated the potential benefit gained simply through adherence to protocols. Nevertheless, these studies frequently lacked appropriate statistical analysis and examined small, and often heterogeneous, patient groups. Larger comparative studies also possessed some of the same flaws; however, taken together the equivalence and, in some cases improvement, in patient outcomes (e.g., greater control of International Normalized Ratios and decreased length of hospital stay) that they demonstrated suggest the value of increased pharmacist participation in anticoagulation therapy. Studies using heparin-based anticoagulation reported similar positive findings and hence support the warfarin results. Both published studies examining financial implications of in-hospital pharmacy management indicated potential for considerable savings. Finally, although we identified no in-hospital studies of community acceptance, positive survey results indicted that the majority of physicians and patients accepted pharmacy-managed outpatient anticoagulation.
Conclusions: The reported outcomes of pharmacy-managed in-hospital anticoagulation therapy appear at least equal, and sometimes superior, to those obtained through standard care; however, the lack of large well-designed trials prevents drawing definitive conclusions. Nevertheless, the continued and likely increased future need for anticoagulation in general and warfarin therapy in particular suggests that increased pharmacist involvement could enhance the quality of patient care.
Similar content being viewed by others
References
Tapson VF, Hyers TM, Waldo AL, et al (2005) Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch Intern Med 165:1458–1464
Gandhi T, Shojania K, Bates D (2001) Protocols for high-risk drugs: reducing adverse drug events related to anticoagulation. Making Health Care Safer: A Critical Analysis of Patient Safety Practices Evidence Report/Technology Assessment: Number 43 AHRQ Publication No 01-E058, Agency for Healthcare Research and Quality, Rockville, MD
Witt DM, Sadler MA, Shanahan RL, Mazzoli G, Tillman DJ (2005) Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 127:1515–1522
Shalansky KF, Sunderji RA (2000) A simple warfarin dosing nomogram for orthopedic prophylaxis. Can J Hosp Pharm 53:40–43
Rivey MP, Wood RD, Allington DR, Stratton TP, Erickson CC, Stenson TA (1995) Pharmacy-managed protocol for warfarin use in orthopedic surgery patients. Am J Health Syst Pharm 52:1310–1316
Burns N (2004) Evaluation of warfarin dosing by pharmacists for elderly medical in-patients. Pharm World Sci 26:232–237
To EK, Pearson GJ (1997) Implementation and evaluation of a pharmacist-assisted warfarin dosing program. Can J Hosp Pharm 50:169–175
Damaske DL, Baird RW (2005) Development and implementation of a pharmacist-managed inpatient warfarin protocol. Proc Bayl Univ Med Cent 18:397–400
Tschol N, Lai DK, Tilley JA, Wong H, Brown GR (2003) Comparison of physician- and pharmacist-managed warfarin sodium treatment in open heart surgery patients. Can J Cardiol 19:1413–1417
Dager WE, Branch JM, King JH, et al (2000) Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother 34:567–572
Boddy C (2001) Pharmacist involvement with warfarin dosing for inpatients. Pharm World Sci 23:31–35
Bond CA, Raehl CL (2004) Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions. Pharmacotherapy 24:953–963
Ellis RF, Stephens MA, Sharp GB (1992) Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. Am J Hosp Pharm 49:387–394
Chenella FC, Klotz TA, Gill MA, et al (1983) Comparison of physician and pharmacist management of anticoagulant therapy of inpatients. Am J Hosp Pharm 40:1642–1645
Saya FG, Coleman LT, Martinoff JT (1985) Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am J Hosp Pharm 42:1965–1969
Rivey MP, Peterson JP (1993) Pharmacy-managed, weight-based heparin protocol. Am J Hosp Pharm 50:279–284
Kershaw B, White RH, Mungall D, Van Houten J, Brettfeld S (1994) Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service. Arch Intern Med 154:1005–1011
Pawloski SJ, Kersh PL (1992) Therapeutic heparin monitoring service in a small community hospital. Hosp Pharm 27:703–706, 723
Shalansky KF, FitzGerald M, Sunderji R, et al (1996) Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation. Pharmacotherapy 16:1076–1084
Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S (1993) The weight-based heparin dosing nomogram compared with a standard care nomogram. Ann Intern Med 119:874–881
Barrett DW (1960) Anticoagulation drugs in the treatment of pulmonary embolism; a controlled clinical trial. Lancet 1:1309–1312
Dobesh PP (2004) Heparin Consensus Group. Unfractionated heparin dosing nomograms: Road maps to where? Pharmacotherapy 24:142S–145S
Mamdani MM, Racine E, McCreadie S, et al (1999) Clinical and economic effectiveness of an inpatient anticoagulation service. Pharmacotherapy 19:1064–1074
Abdelhafiz AH, Wheeldon NM (2003) Use of resources and cost implications of stroke prophylaxis with warfarin for patients with nonvalvular atrial fibrillation. Am J Geriatr Pharmacother 1:53–60
Anderson RJ (2004) Cost analysis of a managed care decentralized outpatient pharmacy anticoagulation service. J Manag Care Pharm 10:159–165
Chiquette E, Amato MG, Bussey HI (1998) Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 158:1641–1647
Menzin J, Boulanger L, Hauch O, et al (2005) Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study. Ann Pharmacother 39:446–451
The economics of anticoagulation: what are the issues? (2004) Am J Manag Care 10(Suppl):S292–S296
Calcagno D, Pubentz M, Carey R (1996) Improving patient satisfaction with warfarin management. Am J Manag Care 2:804–810
Lewis SM, Kroner BA (1997) Patient survey of a pharmacist-managed anticoagulation clinic. Manag Care Interface 10:66–70
Amruso NA (2004) Ability of clinical pharmacists in a community pharmacy setting to manage anticoagulation therapy. J Am Pharm Assoc 44:467–71
Waterman AD, Milligan PE, Banet GA, Gatchel SK, Gage BF (2001) Establishing and running an effective telephone-based anticoagulation service. J Vasc Nurs 19:126–132
Lodwick AD, Sajbel TA (2000) Patient and physician satisfaction with a pharmacist-managed anticoagulation clinic: implications for managed care organizations. Manag Care 9:47–50
Willey ML, Chagan L, Sisca TS, et al (2003) A pharmacist-managed anticoagulation clinic: six-year assessment of patient outcomes. Am J Health Syst Pharm 60:1033–1037
Shalita E, Hurd P, James J, Tullio C, Wuller C (1998) Physician attitudes toward pharmacist-run anticoagulation clinics in Department of Defense Health Services Region 5. J Manag Care Pharm 4:413–419
Harrold LR, Gurwitz JH, Tate JP, et al (2002) Physician attitudes concerning anticoagulation services in the long-term care setting. J Thromb Thrombolysis 14:59–64
Macik BG (2003) The future of anticoagulation clinics. J Thromb Thrombolysis 16:55–59
Cheng TO (1997) Should we just let the anticoagulation service do it? J Gen Intern Med 12:258–259
Spyropoulos AC, Haire W (2003) The clinical thrombosis center and clinical thrombologist: a new US health systems paradigm for the management of venous thromboembolic disease. J Thromb Thrombolysis 15:227–232
McDonough R, Doucette W (2001) Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc 41:682–692
Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM (2005) Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention. J Am Geriatr Soc 53:1912–1920
Bridges GG, Lee MD, Jenkins JK, Stephens MA, Croce MA, Fabian TC (2003) Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: the LEAP Program. J Trauma 54:232–235
Nutescu EA, Wittkowsky AK, Dager WE (2005) Uncertain times for oral anticoagulation therapy. Am J Health Syst Pharm 62:1449
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Donovan, J.L., Drake, J.A., Whittaker, P. et al. Pharmacy-managed anticoagulation: Assessment of in-hospital efficacy and evaluation of financial impact and community acceptance. J Thromb Thrombolysis 22, 23–30 (2006). https://doi.org/10.1007/s11239-006-8328-9
Issue Date:
DOI: https://doi.org/10.1007/s11239-006-8328-9